Radiomer Therapeutics Revenue

Biotechnology Research • Houston, Texas, United States • 1-10 Employees

Radiomer Therapeutics revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Radiomer Therapeutics

Sougata Dey

Director of Chemistry

Company overview

Headquarters	Houston, Texas, United States
Website	radiomer.com
NAICS	541714
Founded	2023
Employees	1-10
Socials

About Radiomer Therapeutics

Novel radiopharmaceutical / radioligand therapy platform that leverages Raptamersᵀᴹ (peptide-oligonucleotide hybrids) as a targeting moiety / vector

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Employees by Department

Radiomer Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Radiomer Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-29	2	N/A

Funding Insights

Number of funding rounds

Radiomer Therapeutics Tech Stack

Discover the technologies and tools that power Radiomer Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Emotion

Development

Squarespace Commerce

Ecommerce

reCAPTCHA

Security

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

Frequently asked questions

Radiomer Therapeutics is located in Houston, Texas, US.

Radiomer Therapeutics generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Radiomer Therapeutics has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Radiomer Therapeutics was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

Radiomer Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Radiomer Therapeutics

Sougata Dey

Director of Chemistry

4.8

40,000 users